-
1
-
-
0033863859
-
Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia
-
Basso, C., G. Thiene, D. Corrado, G. Buja, P. Melacini, and A. Nava. 2000. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum. Pathol. 31:988-998. http://dx.doi.org/10.1053/hupa.2000.16659
-
(2000)
Hum. Pathol.
, vol.31
, pp. 988-998
-
-
Basso, C.1
Thiene, G.2
Corrado, D.3
Buja, G.4
Melacini, P.5
Nava, A.6
-
2
-
-
0037132681
-
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
-
Choudhury, L., H. Mahrholdt, A. Wagner, K.M. Choi, M.D. Elliott, F.J. Klocke, R.O. Bonow, R.M. Judd, and R.J. Kim. 2002. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 40:2156-2164. http://dx.doi.org/10.1016/S0735-1097(02)02602-5
-
(2002)
J. Am. Coll. Cardiol.
, vol.40
, pp. 2156-2164
-
-
Choudhury, L.1
Mahrholdt, H.2
Wagner, A.3
Choi, K.M.4
Elliott, M.D.5
Klocke, F.J.6
Bonow, R.O.7
Judd, R.M.8
Kim, R.J.9
-
3
-
-
84862673626
-
Cellintrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy
-
Chuan, P., S. Sivaramakrishnan, E.A. Ashley, and J.A. Spudich. 2012. Cellintrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy. Biophys. J. 102:2782-2790. http://dx.doi.org/10.1016/j.bpj.2012.04.049
-
(2012)
Biophys. J.
, vol.102
, pp. 2782-2790
-
-
Chuan, P.1
Sivaramakrishnan, S.2
Ashley, E.A.3
Spudich, J.A.4
-
4
-
-
77951702049
-
Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development
-
Colson, B.A., M.R. Locher, T. Bekyarova, J.R. Patel, D.P. Fitzsimons, T.C. Irving, and R.L. Moss. 2010. Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development. J. Physiol. 588:981-993. http://dx.doi.org/10.1113/jphysiol.2009.183897
-
(2010)
J. Physiol.
, vol.588
, pp. 981-993
-
-
Colson, B.A.1
Locher, M.R.2
Bekyarova, T.3
Patel, J.R.4
Fitzsimons, D.P.5
Irving, T.C.6
Moss, R.L.7
-
5
-
-
34547111798
-
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay
-
Debold, E.P., J.P. Schmitt, J.B. Patlak, S.E. Beck, J.R. Moore, J.G. Seidman, C. Seidman, and D.M. Warshaw. 2007. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am. J. Physiol. Heart Circ. Physiol. 293:H284-H291. http://dx.doi.org/10.1152/ajpheart.00128.2007
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.293
-
-
Debold, E.P.1
Schmitt, J.P.2
Patlak, J.B.3
Beck, S.E.4
Moore, J.R.5
Seidman, J.G.6
Seidman, C.7
Warshaw, D.M.8
-
6
-
-
0033653534
-
An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
-
Fatkin, D., B.K. McConnell, J.O. Mudd, C. Semsarian, I.G. Moskowitz, F.J. Schoen, M. Giewat, C.E. Seidman, and J.G. Seidman. 2000. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J. Clin. Invest. 106:1351-1359. http://dx.doi.org/10.1172/JCI11093
-
(2000)
J. Clin. Invest.
, vol.106
, pp. 1351-1359
-
-
Fatkin, D.1
McConnell, B.K.2
Mudd, J.O.3
Semsarian, C.4
Moskowitz, I.G.5
Schoen, F.J.6
Giewat, M.7
Seidman, C.E.8
Seidman, J.G.9
-
7
-
-
0030067394
-
A mouse model of familial hypertrophic cardiomyopathy
-
Geisterfer-Lowrance, A.A., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, and J.G. Seidman. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734. http://dx.doi.org/10.1126/science.272.5262.731
-
(1996)
Science
, vol.272
, pp. 731-734
-
-
Geisterfer-Lowrance, A.A.1
Christe, M.2
Conner, D.A.3
Ingwall, J.S.4
Schoen, F.J.5
Seidman, C.E.6
Seidman, J.G.7
-
8
-
-
77950108961
-
Hypertrophic cardiomyopathy
-
Ho, C.Y. 2010. Hypertrophic cardiomyopathy. Heart Fail. Clin. 6:141-159. http://dx.doi.org/10.1016/j.hfc.2009.12.001
-
(2010)
Heart Fail. Clin.
, vol.6
, pp. 141-159
-
-
Ho, C.Y.1
-
9
-
-
77955303165
-
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
-
Ho, C.Y., B. López, O.R. Coelho-Filho, N.K. Lakdawala, A.L. Cirino, P. Jarolim, R. Kwong, A. González, S.D. Colan, J.G. Seidman, et al. 2010. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N. Engl. J. Med. 363:552-563. http://dx.doi.org/10.1056/NEJMoa1002659
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 552-563
-
-
Ho, C.Y.1
López, B.2
Coelho-Filho, O.R.3
Lakdawala, N.K.4
Cirino, A.L.5
Jarolim, P.6
Kwong, R.7
González, A.8
Colan, S.D.9
Seidman, J.G.10
-
10
-
-
34250201129
-
Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy
-
Kim, J.B., G.J. Porreca, L. Song, S.C. Greenway, J.M. Gorham, G.M. Church, C.E. Seidman, and J.G. Seidman. 2007. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science. 316:1481-1484. http://dx.doi.org/10.1126/science.1137325
-
(2007)
Science
, vol.316
, pp. 1481-1484
-
-
Kim, J.B.1
Porreca, G.J.2
Song, L.3
Greenway, S.C.4
Gorham, J.M.5
Church, G.M.6
Seidman, C.E.7
Seidman, J.G.8
-
11
-
-
38149029264
-
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice
-
Kim, Y., D. Phan, E. van Rooij, D.Z. Wang, J. McAnally, X. Qi, J.A. Richardson, J.A. Hill, R. Bassel-Duby, and E.N. Olson. 2008. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 118:124-132. http://dx.doi.org/10.1172/JCI33255
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 124-132
-
-
Kim, Y.1
Phan, D.2
van Rooij, E.3
Wang, D.Z.4
McAnally, J.5
Qi, X.6
Richardson, J.A.7
Hill, J.A.8
Bassel-Duby, R.9
Olson, E.N.10
-
12
-
-
78149242336
-
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy
-
Konno, T., D. Chen, L. Wang, H. Wakimoto, P. Teekakirikul, M. Nayor, M. Kawana, S. Eminaga, J.M. Gorham, K. Pandya, et al. 2010. Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA. 107:18097-18102. http://dx.doi.org/10.1073/pnas.1012826107
-
(2010)
Proc. Natl. Acad. Sci. USA.
, vol.107
, pp. 18097-18102
-
-
Konno, T.1
Chen, D.2
Wang, L.3
Wakimoto, H.4
Teekakirikul, P.5
Nayor, M.6
Kawana, M.7
Eminaga, S.8
Gorham, J.M.9
Pandya, K.10
-
13
-
-
0028967729
-
Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy
-
Lankford, E.B., N.D. Epstein, L. Fananapazir, and H.L. Sweeney. 1995. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95:1409-1414. http://dx.doi.org/10.1172/JCI117795
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 1409-1414
-
-
Lankford, E.B.1
Epstein, N.D.2
Fananapazir, L.3
Sweeney, H.L.4
-
14
-
-
79952781139
-
Cardiac myosin activation: a potential therapeutic approach for systolic heart failure
-
Malik, F.I., J.J. Hartman, K.A. Elias, B.P. Morgan, H. Rodriguez, K. Brejc, R.L. Anderson, S.H. Sueoka, K.H. Lee, J.T. Finer, et al. 2011. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science. 331:1439-1443. http://dx.doi.org/10.1126/science.1200113
-
(2011)
Science
, vol.331
, pp. 1439-1443
-
-
Malik, F.I.1
Hartman, J.J.2
Elias, K.A.3
Morgan, B.P.4
Rodriguez, H.5
Brejc, K.6
Anderson, R.L.7
Sueoka, S.H.8
Lee, K.H.9
Finer, J.T.10
-
15
-
-
0347989434
-
Hypertrophic cardiomyopathy: an important global disease
-
Maron, B.J. 2004. Hypertrophic cardiomyopathy: an important global disease. Am. J. Med. 116:63-65. http://dx.doi.org/10.1016/j.amjmed.2003.10.012
-
(2004)
Am. J. Med.
, vol.116
, pp. 63-65
-
-
Maron, B.J.1
-
16
-
-
78349293794
-
Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy
-
Maron, B.J. 2010. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ. J. 74:2271-2282. http://dx.doi.org/10.1253/circj.CJ-10-0921
-
(2010)
Circ. J.
, vol.74
, pp. 2271-2282
-
-
Maron, B.J.1
-
17
-
-
0030057106
-
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles
-
Maron, B.J., J. Shirani, L.C. Poliac, R. Mathenge, W.C. Roberts, and F.O. Mueller. 1996. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 276:199-204. http://dx.doi.org/10.1001/jama.1996.03540030033028
-
(1996)
JAMA
, vol.276
, pp. 199-204
-
-
Maron, B.J.1
Shirani, J.2
Poliac, L.C.3
Mathenge, R.4
Roberts, W.C.5
Mueller, F.O.6
-
18
-
-
79960564849
-
How do mutations in contractile proteins cause the primary familial cardiomyopathies? J
-
Marston, S.B. 2011. How do mutations in contractile proteins cause the primary familial cardiomyopathies? J. Cardiovasc. Transl. Res. 4:245-255. http://dx.doi.org/10.1007/s12265-011-9266-2
-
(2011)
Cardiovasc. Transl. Res.
, vol.4
, pp. 245-255
-
-
Marston, S.B.1
-
19
-
-
69449090360
-
Circulating transforming growth factor-beta in Marfan syndrome
-
GenTAC. Consortium
-
Matt, P., F. Schoenhoff, J. Habashi, T. Holm, C. Van Erp, D. Loch, O.D. Carlson, B.F. Griswold, Q. Fu, J. De Backer, et al; GenTAC Consortium. 2009. Circulating transforming growth factor-beta in Marfan syndrome. Circulation. 120: 526-532. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.841981
-
(2009)
Circulation
, vol.120
, pp. 526-532
-
-
Matt, P.1
Schoenhoff, F.2
Habashi, J.3
Holm, T.4
Van Erp, C.5
Loch, D.6
Carlson, O.D.7
Griswold, B.F.8
Fu, Q.9
De Backer, J.10
-
20
-
-
34548371401
-
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling
-
Oka, T., J. Xu, R.A. Kaiser, J. Melendez, M. Hambleton, M.A. Sargent, A. Lorts, E.W. Brunskill, G.W. Dorn II, S.J. Conway, et al. 2007. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 101:313-321. http://dx.doi.org/10.1161/CIRCRESAHA.107.149047
-
(2007)
Circ. Res.
, vol.101
, pp. 313-321
-
-
Oka, T.1
Xu, J.2
Kaiser, R.A.3
Melendez, J.4
Hambleton, M.5
Sargent, M.A.6
Lorts, A.7
Brunskill, E.W.8
Dorn II, G.W.9
Conway, S.J.10
-
21
-
-
41749090906
-
Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex
-
Palmer, B.M., Y. Wang, P. Teekakirikul, J.T. Hinson, D. Fatkin, S. Strouse, P. Vanburen, C.E. Seidman, J.G. Seidman, and D.W. Maughan. 2008. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am. J. Physiol. Heart Circ. Physiol. 294:H1939-H1947. http://dx.doi.org/10.1152/ajpheart.00644.2007
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
-
-
Palmer, B.M.1
Wang, Y.2
Teekakirikul, P.3
Hinson, J.T.4
Fatkin, D.5
Strouse, S.6
Vanburen, P.7
Seidman, C.E.8
Seidman, J.G.9
Maughan, D.W.10
-
22
-
-
67249152096
-
Cardiac fibroblasts: at the heart of myocardial remodeling
-
Porter, K.E., and N.A. Turner. 2009. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123:255-278. http://dx.doi.org/10.1016/j.pharmthera.2009.05.002
-
(2009)
Pharmacol. Ther.
, vol.123
, pp. 255-278
-
-
Porter, K.E.1
Turner, N.A.2
-
23
-
-
0033921695
-
Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts
-
Ruwhof, C., A.E. van Wamel, J.M. Egas, and A. van der Laarse. 2000. Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts. Mol. Cell. Biochem. 208:89-98. http://dx.doi.org/10.1023/A:1007046105745
-
(2000)
Mol. Cell. Biochem.
, vol.208
, pp. 89-98
-
-
Ruwhof, C.1
van Wamel, A.E.2
Egas, J.M.3
van der Laarse, A.4
-
24
-
-
79953037494
-
Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history
-
Seidman, C.E., and J.G. Seidman. 2011. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ. Res. 108:743-750. http://dx.doi.org/10.1161/CIRCRESAHA.110.223834
-
(2011)
Circ. Res.
, vol.108
, pp. 743-750
-
-
Seidman, C.E.1
Seidman, J.G.2
-
25
-
-
78649857349
-
Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice
-
Shan, J., M.J. Betzenhauser, A. Kushnir, S. Reiken, A.C. Meli, A. Wronska, M. Dura, B.X. Chen, and A.R. Marks. 2010. Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. J. Clin. Invest. 120:4375-4387. http://dx.doi.org/10.1172/JCI37649
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 4375-4387
-
-
Shan, J.1
Betzenhauser, M.J.2
Kushnir, A.3
Reiken, S.4
Meli, A.C.5
Wronska, A.6
Dura, M.7
Chen, B.X.8
Marks, A.R.9
-
26
-
-
77952519774
-
Sarcomere control mechanisms and the dynamics of the cardiac cycle
-
Solaro, R.J. 2010. Sarcomere control mechanisms and the dynamics of the cardiac cycle. J. Biomed. Biotechnol. 2010:105648. http://dx.doi.org/10.1155/2010/105648
-
(2010)
J. Biomed. Biotechnol.
, vol.2010
, pp. 105648
-
-
Solaro, R.J.1
-
27
-
-
0032523194
-
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy
-
Spindler, M., K.W. Saupe, M.E. Christe, H.L. Sweeney, C.E. Seidman, J.G. Seidman, and J.S. Ingwall. 1998. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:1775-1783. http://dx.doi.org/10.1172/JCI1940
-
(1998)
J. Clin. Invest.
, vol.101
, pp. 1775-1783
-
-
Spindler, M.1
Saupe, K.W.2
Christe, M.E.3
Sweeney, H.L.4
Seidman, C.E.5
Seidman, J.G.6
Ingwall, J.S.7
-
28
-
-
0027980111
-
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction
-
Sweeney, H.L., A.J. Straceski, L.A. Leinwand, B.A. Tikunov, and L. Faust. 1994. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269:1603-1605.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 1603-1605
-
-
Sweeney, H.L.1
Straceski, A.J.2
Leinwand, L.A.3
Tikunov, B.A.4
Faust, L.5
-
29
-
-
77957854278
-
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
-
Teekakirikul, P., S. Eminaga, O. Toka, R. Alcalai, L. Wang, H. Wakimoto, M. Nayor, T. Konno, J.M. Gorham, C.M. Wolf, et al. 2010. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-?. J. Clin. Invest. 120:3520-3529. http://dx.doi.org/10.1172/JCI42028
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 3520-3529
-
-
Teekakirikul, P.1
Eminaga, S.2
Toka, O.3
Alcalai, R.4
Wang, L.5
Wakimoto, H.6
Nayor, M.7
Konno, T.8
Gorham, J.M.9
Wolf, C.M.10
-
30
-
-
0034646743
-
Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy
-
Tyska, M.J., E. Hayes, M. Giewat, C.E. Seidman, J.G. Seidman, and D.M. Warshaw. 2000. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ. Res. 86:737-744. http://dx.doi.org/10.1161/01.RES.86.7.737
-
(2000)
Circ. Res.
, vol.86
, pp. 737-744
-
-
Tyska, M.J.1
Hayes, E.2
Giewat, M.3
Seidman, C.E.4
Seidman, J.G.5
Warshaw, D.M.6
-
31
-
-
0036322768
-
Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes
-
van Wamel, A.J., C. Ruwhof, L.J. van der Valk-Kokshoorn, P.I. Schrier, and A. van der Laarse. 2002. Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes. Mol. Cell. Biochem. 236:147-153. http://dx.doi.org/10.1023/A:1016138813353
-
(2002)
Mol. Cell. Biochem.
, vol.236
, pp. 147-153
-
-
van Wamel, A.J.1
Ruwhof, C.2
van der Valk-Kokshoorn, L.J.3
Schrier, P.I.4
van der Laarse, A.5
-
32
-
-
77952966596
-
Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy
-
Wang, L., J.G. Seidman, and C.E. Seidman. 2010. Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann. Intern. Med. 152:513-520.
-
(2010)
Ann. Intern. Med.
, vol.152
, pp. 513-520
-
-
Wang, L.1
Seidman, J.G.2
Seidman, C.E.3
-
33
-
-
29144506700
-
Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia
-
Wolf, C.M., I.P. Moskowitz, S. Arno, D.M. Branco, C. Semsarian, S.A. Bernstein, M. Peterson, M. Maida, G.E. Morley, G. Fishman, et al. 2005. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc. Natl. Acad. Sci. USA. 102:18123-18128. http://dx.doi.org/10.1073/pnas.0509145102
-
(2005)
Proc. Natl. Acad. Sci. USA.
, vol.102
, pp. 18123-18128
-
-
Wolf, C.M.1
Moskowitz, I.P.2
Arno, S.3
Branco, D.M.4
Semsarian, C.5
Bernstein, S.A.6
Peterson, M.7
Maida, M.8
Morley, G.E.9
Fishman, G.10
|